Design and In-silico Molecular Docking of NMDA NR2B Receptor Antagonist and Pharmacokinetic Prediction of Some Piperazine Sulfonyl Amine Derivatives for Alzheimer’s Disease
Abstract:Alzheimer's disease is a rare and progressive neurologic disease caused by degeneration of neurons within the brain that causes the brain to shrink (atrophy) and brain cells to die. In the US, approximately 5.5 million people are affected, and the prevalence worldwide is estimated to be as high as 24 million. Treatment is available to reduce the symptoms but no permanent cure. NMDA receptors play a crucial role in the treatment of Alzheimer's. Our aim and objective of the present work are to design some pipera… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.